| Literature DB >> 27827853 |
Nguyen T Nhung1, Nguyen V Cuong2, Guy Thwaites3,4, Juan Carrique-Mas5,6.
Abstract
Southeast Asia is an area of great economic dynamism. In recent years, it has experienced a rapid rise in the levels of animal product production and consumption. The region is considered to be a hotspot for infectious diseases and antimicrobial resistance (AMR). We reviewed English-language peer-reviewed publications related to antimicrobial usage (AMU) and AMR in animal production, as well as antimicrobial residues in meat and fish from 2000 to 2016, in the region. There is a paucity of data from most countries and for most bacterial pathogens. Most of the published work relates to non-typhoidal Salmonella (NTS), Escherichia coli (E. coli), and Campylobacter spp. (mainly from Vietnam and Thailand), Enterococcus spp. (Malaysia), and methicillin-resistant Staphylococcus aureus (MRSA) (Thailand). However, most studies used the disk diffusion method for antimicrobial susceptibility testing; breakpoints were interpreted using Clinical Standard Laboratory Institute (CSLI) guidelines. Statistical models integrating data from publications on AMR in NTS and E. coli studies show a higher overall prevalence of AMR in pig isolates, and an increase in levels of AMR over the years. AMU studies (mostly from Vietnam) indicate very high usage levels of most types of antimicrobials, including beta-lactams, aminoglycosides, macrolides, and quinolones. This review summarizes information about genetic determinants of resistance, most of which are transferrable (mostly plasmids and integrons). The data in this review provide a benchmark to help focus research and policies on AMU and AMR in the region.Entities:
Keywords: E. coli; Salmonella; animal production; antimicrobial consumption; antimicrobial residues; antimicrobial resistance; chickens; farms; pigs
Year: 2016 PMID: 27827853 PMCID: PMC5187518 DOI: 10.3390/antibiotics5040037
Source DB: PubMed Journal: Antibiotics (Basel) ISSN: 2079-6382
Figure 1Summary results of estimates of prevalence of antimicrobial resistance (AMR) in Escherichia coli isolates of animal origin (N = 23). Blue = aquaculture, Red = chicken, Green = pig, Grey = other species. Circle = Thailand, triangle = Vietnam, square = Indonesia. Key: AMP = ampicillin, AMC = augmentin, CAZ = ceftazidime, CLT = cephalothin, CN = gentamicin, S = streptomycin, CIP = ciprofloxacin, NAL = nalidixic acid, C = chloramphenicol, SXT = co-trimoxazole, TE = tetracycline. Boxplots indicate median and 75% interquartile range.
Figure 2Summary results of estimates of prevalence of AMR in non-typhoidal Salmonella (NTS) isolates of animal origin (N = 41). Blue = aquaculture, Red = chicken, Green = pig, Grey = other species. Circle = Thailand, triangle = Vietnam, square = other countries (Cambodia, Lao PDR, and Malaysia). Key: AMP = ampicillin, AMC = augmentin, CAZ = ceftazidime, CLT = cephalothin, CN = gentamicin, S = streptomycin, CIP = ciprofloxacin, NAL = nalidixic acid, C = chloramphenicol, SXT = co-trimoxazole, TE = tetracycline. Boxplots indicate median and 75% interquartile range.
Odds ratios (ORs) derived from multivariable logistic regression models investigating risk factors for positivity among Escherichia coli and non-typhoidal Salmonella (NTS) isolates against five antimicrobials in Southeast Asia (SEA). The reported p-values refer to the significance levels of the investigated variable.
| Variable | Non-typhoidal | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| AMP (3294) § | CN (2667) | C (2799) | TE (3231) | CIP (2857) | AMP (3849) | CN (3144) | C (3339) | TE (3352) | CIP (4026) | |
| Host type (baseline = Chicken) | ||||||||||
| Aquaculture | 0.03 *** | 0.16 | 0.04 *** | 0.12 *** | 0.71 | NC | NC | 0.15 ** | 0.05 *** | 0.73 |
| Pig | 2.33 *** | 2.35 *** | 3.26 *** | 6.65 *** | 1.45 ** | 2.86 *** | 3.98 *** | 1.46 *** | 3.89 *** | 3.19 *** |
| Other a | 0.93 | 0.17 *** | 0.29 *** | 0.17 *** | 0.43 *** | 0.32 *** | 0.54 * | 0.31 *** | 0.21 *** | 0.33 ** |
| Country (baseline = Other b) | ||||||||||
| Thailand | 1.75 * | 1 (baseline) | 1.98 | 1 (baseline) | 1 (baseline) | 2.52 *** | 8.16 ** | 7.55 *** | 4.12 *** | 0.02 *** |
| Vietnam | 2.19 ** | 0.44 *** | 2.87 ** | 5.31 *** | 0.91 | 1.18 | 5.40 * | 11.10 *** | 4.10 *** | 0.41 |
| Period (baseline = 2007 or earlier) | ||||||||||
| 2008–2016 | 2.93 *** | 0.68 * | 1.39 * | 0.82 | 2.46 *** | 3.73 *** | 1.12 | 1.39 *** | 1.38 ** | 9.59 *** |
§ Number of colonies investigated; * p < 0.05; ** p < 0.01; *** p < 0.001; Other a = Cattle, buffalo, ducks, small wild mammals; Other b = Countries other than Thailand and Vietnam; NC = Not calculated due to insufficient data.
Summary of prevalence estimates (N = 25) of resistance against antimicrobials tested among Campylobacter spp. isolates from a total of 18 publications in SEA.
| Variable | Total No. Estimates | AMP | CN | C | TE | NAL | CIP | ERY | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| n* | median | n* | median | n* | median | n* | median | n* | median | n* | median | n* | median | |||
| Host species | Pig | 5 | 1 | 51.2 | 4 | 10.1 | 4 | 2.0 | 4 | 84.2 | 2 | 89.6 | 5 | 84.5 | 5 | 66.0 |
| Poultry | 19 | 10 | 37.1 | 14 | 11.0 | 9 | 2.2 | 13 | 71.0 | 11 | 83.3 | 17 | 66.6 | 17 | 23.7 | |
| Country | Thailand | 15 | 5 | 31.2 | 9 | 0.0 | 8 | 0.0 | 12 | 77.2 | 7 | 79.6 | 15 | 81.2 | 13 | 50.5 |
| Vietnam | 6 | 4 | 57.9 | 5 | 16.2 | 4 | 9.9 | 2 | 73.0 | 6 | 92.0 | 6 | 44.5 | 6 | 62.5 | |
| Others** | 4 | 2 | 55.7 | 4 | 18.8 | 2 | 11.2 | 3 | 80.9 | 1 | 58.3 | 2 | 48.1 | 4 | 21.9 | |
| Total | 25 | 11 | 40.0 | 18 | 11.0 | 14 | 2.0 | 17 | 76.6 | 14 | 83.6 | 23 | 70.4 | 23 | 46.2 | |
AMP = ampicillin; CN = gentamicin; C = chloramphenicol; TE = tetracycline; NAL = nalidixic acid; CIP = ciprofloxacin; ERY = erythromycin. * n = number of estimates where the antimicrobial was investigated; ** Cambodia, Malaysia, and the Philippines.
Summary of phenotypic prevalence of AMR in bacteria isolated from aquaculture products (data extracted from eight publications).
| Ref. | Country | Species | Host Species | Location | No. Isolates | Prevalence of AMR |
|---|---|---|---|---|---|---|
| [ | Thailand | Fish | Chicken-fish farm | 27 | OTC (37%), SMX (19%), ERY (11%), C (7%), CIP (4%) | |
| [ | Thailand | Fish | Fish farm (no chicken manure) | 45 | S (22%), OTC (13%), ERY (2%), C (2%), CIP (0%) | |
| [ | Thailand | Fish | Fish farm using chicken manure | 97 | S (72%), OTC (75%), ERY (91%), C (8%), CIP (15%) | |
| [ | Thailand | Fish | Fish farm (no chicken manure) | 69 | S (31%), ERY (23%), OTC (16%), CIP (6%), C (0%) | |
| [ | Vietnam | Fish | Diseased fish | 64 | S (83%), OTC (81%), TMP (73.4%), FLU (8%), OA (6%), ENR (5%), C (0%), NIT (0%), AMX (0%), AMC (0%), KA (0%), CN(0%), NEO (0%), FFC (0%) | |
| [ | Malaysia and Indonesia | Fish | Diseased fish | 4 | OTC (100%), AMP (0%), ERY (0%), FFL (0%), LCM (0%) | |
| [ | Thailand | Shrimp | Market | 67 | AMP (100%), TE (100%), BAC (100%), CLI (100%), S (47%), SXT (47%), C (47%), RIF (47%), NAL (12%) | |
| [ | Vietnam | Fish | Diseased fish | 19 | SXT (89%), FFC (47%), C (47%), OTC (31%), NIT (0%) | |
| [ | Vietnam | Fish | Fish farm | 116 | AMP (99%), SXT (93%), NIT (90%), NAL (93%), C (89%), TE (30%), S (28%), DOX (25%), CN (16%), KA (12%), NOR (9%), CIP (9%), NEO (3%) | |
| [ | Vietnam | Fish | Fish farm | 92 | AMP (94%), SXT (61%), NAL (52%), TE (34%), C (31%), S (31%), NIT (25%), DOX (15%), KA (12%), CIP (8%), CN (6%), NEO (5%), NOR (4%) | |
| [ | Thailand | Fish | Diseased fish | 4 | AMP (100%), CN (100%), C (100%), ENR (100%), OXA (100%), NIT (100%), PEN (75%), FFC (75%), SXT (50%), ERY (50%) | |
| [ | Thailand | Fish | Diseased fish | 144 | OA (100%), CN (100%), SMX (100%), TMP (93%), OTC (12%), NOR (2%), LCM (1%), AMP (0%), C (0%), ERY (0%) |
Key: AMP = ampicillin, AMX = amoxicillin, AMC = augmentin, BAC = bacitracin, C = chloramphenicol, CIP = ciprofloxacin, CLI = clindamycin, CN = gentamicin, DOX = doxycycline, ENR = enrofloxacin, ERY = erythromycin, FLU = flumequin, FFC = flofenicol, FOM = fosfomycin, KA = kanamycin, LCM = lincomycin, NAL = nalidixic acid, NEO = neomycin, NOR = norfloxacin, NIT = nitrofurantoin, OA = oxolinic acid, OXA = oxacillin, OTC = oxytetracycline, PEN = penicillin, S = streptomycin, SMX = sulfamethoxazole, SXT = co-trimoxazole, TE = tetracycline, TMP = trimethoprim, RIF = rifampicin.
Antimicrobial resistance (AMR) genes identified in bacterial isolates reported in 33 publications.
| Antimicrobial Class | NTS | Others | ||||
|---|---|---|---|---|---|---|
| n | Gene(s) Detected | n | Gene(s) Detected | n | Gene(s) Detected and Host Bacteria | |
| Tetracycline | 4 | 5 | 11 | |||
| Quilonone | 2 | 3 | 4 | |||
| 4 | 1 | |||||
| Diaminopyrimidine | 7 | 8 | 1 | |||
| 5 | 10 | 2 | ||||
| 1 | MOXM, DHAM | 1 | ||||
| Aminoglycoside | 8 | 10 | 2 | |||
| 2 | 3 | |||||
| 3 | 3 | 2 | ||||
| Sulphonamide | 5 | 4 | 2 | |||
| Phenicol | 4 | 3 | 3 | |||
| Polymixin | 3 | |||||
| Lincosamide | 2 | |||||
| Macrolide | 7 | 23S rRNA (CA), | ||||
| Polypeptide | 2 | |||||
n = Number of publications; AC = Acinetobacter spp., AE = Aeromonas spp., AP = Avibacterium paragallinarum, BA = Bacillus spp., CA = Campylobacter spp., EN = Enterococcus spp., KL = Klebsiella spp., PS = Pseudomonas spp., MRSA = Methicillin-resistant Staphylococcus aureus, SD = Streptococcus dysgalactiae, SS = Streptococcus suis.